These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 27927767)

  • 1. T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers.
    Palma M; Gentilcore G; Heimersson K; Mozaffari F; Näsman-Glaser B; Young E; Rosenquist R; Hansson L; Österborg A; Mellstedt H
    Haematologica; 2017 Mar; 102(3):562-572. PubMed ID: 27927767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia.
    Brusa D; Serra S; Coscia M; Rossi D; D'Arena G; Laurenti L; Jaksic O; Fedele G; Inghirami G; Gaidano G; Malavasi F; Deaglio S
    Haematologica; 2013 Jun; 98(6):953-63. PubMed ID: 23300177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion of a CD8(+)PD-1(+) replicative senescence phenotype in early stage CLL patients is associated with inverted CD4:CD8 ratios and disease progression.
    Nunes C; Wong R; Mason M; Fegan C; Man S; Pepper C
    Clin Cancer Res; 2012 Feb; 18(3):678-87. PubMed ID: 22190592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.
    Lechner A; Schlößer H; Rothschild SI; Thelen M; Reuter S; Zentis P; Shimabukuro-Vornhagen A; Theurich S; Wennhold K; Garcia-Marquez M; Tharun L; Quaas A; Schauss A; Isensee J; Hucho T; Huebbers C; von Bergwelt-Baildon M; Beutner D
    Oncotarget; 2017 Jul; 8(27):44418-44433. PubMed ID: 28574843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deregulated Expression of Immune Checkpoints on Circulating CD4 T Cells May Complicate Clinical Outcome and Response to Treatment with Checkpoint Inhibitors in Multiple Myeloma Patients.
    Kulikowska de Nałęcz A; Ciszak L; Usnarska-Zubkiewicz L; Frydecka I; Pawlak E; Szmyrka M; Kosmaczewska A
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I-II study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukemia (CLL): effects on T cells and immune checkpoints.
    Winqvist M; Mozaffari F; Palma M; Eketorp Sylvan S; Hansson L; Mellstedt H; Österborg A; Lundin J
    Cancer Immunol Immunother; 2017 Jan; 66(1):91-102. PubMed ID: 27815572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-1 upregulated on regulatory T cells during chronic virus infection enhances the suppression of CD8+ T cell immune response via the interaction with PD-L1 expressed on CD8+ T cells.
    Park HJ; Park JS; Jeong YH; Son J; Ban YH; Lee BH; Chen L; Chang J; Chung DH; Choi I; Ha SJ
    J Immunol; 2015 Jun; 194(12):5801-11. PubMed ID: 25934860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic T-Lymphocyte-Associated Antigen 4 (CTLA-4)- and Programmed Death 1 (PD-1)-Mediated Regulation of Monofunctional and Dual Functional CD4
    Rajamanickam A; Munisankar S; Dolla C; Nutman TB; Babu S
    Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31570560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impacts of zanubrutinib on immune cells in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Zou YX; Zhu HY; Li XT; Xia Y; Miao KR; Zhao SS; Wu YJ; Wang L; Xu W; Li JY
    Hematol Oncol; 2019 Oct; 37(4):392-400. PubMed ID: 31420873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Numbers of CD8+PD-1+ and CD4+PD-1+ Cells in Peripheral Blood of Patients with Chronic Lymphocytic Leukemia Are Independent of Binet Stage and Are Significantly Higher Compared to Healthy Volunteers.
    Novák M; Procházka V; Turcsányi P; Papajík T
    Acta Haematol; 2015; 134(4):208-14. PubMed ID: 26066608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expansion of CMV-specific CD8+CD45RA+CD27- T cells in B-cell chronic lymphocytic leukemia.
    Mackus WJ; Frakking FN; Grummels A; Gamadia LE; De Bree GJ; Hamann D; Van Lier RA; Van Oers MH
    Blood; 2003 Aug; 102(3):1057-63. PubMed ID: 12689926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency and functional characterization of exhausted CD8
    Taghiloo S; Allahmoradi E; Tehrani M; Hossein-Nataj H; Shekarriz R; Janbabaei G; Abediankenari S; Asgarian-Omran H
    Eur J Haematol; 2017 Jun; 98(6):622-631. PubMed ID: 28306177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel method using blinatumomab for efficient, clinical-grade expansion of polyclonal T cells for adoptive immunotherapy.
    Golay J; D'Amico A; Borleri G; Bonzi M; Valgardsdottir R; Alzani R; Cribioli S; Albanese C; Pesenti E; Finazzi MC; Quaresmini G; Nagorsen D; Introna M; Rambaldi A
    J Immunol; 2014 Nov; 193(9):4739-47. PubMed ID: 25267972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunophenotypic and DNA genotypic analysis of T-cell and NK-cell subpopulations in patients with B-cell chronic lymphocytic leukaemia (B-CLL).
    Frolova EA; Richards SJ; Jones RA; Rawstron A; Master PS; Teasdale J; Short M; Jack AS; Scott CS
    Leuk Lymphoma; 1995 Jan; 16(3-4):307-18. PubMed ID: 7719238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal T-cell function in B-cell chronic lymphocytic leukaemia.
    Scrivener S; Goddard RV; Kaminski ER; Prentice AG
    Leuk Lymphoma; 2003 Mar; 44(3):383-9. PubMed ID: 12688308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD84 regulates PD-1/PD-L1 expression and function in chronic lymphocytic leukemia.
    Lewinsky H; Barak AF; Huber V; Kramer MP; Radomir L; Sever L; Orr I; Mirkin V; Dezorella N; Shapiro M; Cohen Y; Shvidel L; Seiffert M; Herishanu Y; Becker-Herman S; Shachar I
    J Clin Invest; 2018 Dec; 128(12):5465-5478. PubMed ID: 30277471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher frequency of the CTLA-4
    Chen Y; Tan J; Huang S; Huang X; Huang J; Chen J; Yu Z; Lu Y; Weng J; Du X; Li Y; Zha X; Chen S
    Asia Pac J Clin Oncol; 2020 Apr; 16(2):e12-e18. PubMed ID: 31612643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanded CD8+ T cells of murine and human CLL are driven into a senescent KLRG1+ effector memory phenotype.
    Göthert JR; Eisele L; Klein-Hitpass L; Weber S; Zesewitz ML; Sellmann L; Röth A; Pircher H; Dührsen U; Dürig J
    Cancer Immunol Immunother; 2013 Nov; 62(11):1697-1709. PubMed ID: 24022692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTLA-4 and its ligands on the surface of T- and B-lymphocyte subsets in chronic hepatitis B virus infection.
    Wongjitrat C; Sukwit S; Chuenchitra T; Seangjaruk P; Rojanasang P; Romputtan P; Srisurapanon S
    J Med Assoc Thai; 2013 Jan; 96 Suppl 1():S54-9. PubMed ID: 23724456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid Cancer.
    Severson JJ; Serracino HS; Mateescu V; Raeburn CD; McIntyre RC; Sams SB; Haugen BR; French JD
    Cancer Immunol Res; 2015 Jun; 3(6):620-30. PubMed ID: 25701326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.